Take Choice into its first studies in women.
We are preparing the round that funds the first placements of Choice in women and the set-up of a multi-centre pilot study. Investor materials are shared after an introduction, under confidentiality.
Or write to peter@choice.nu
What the next round funds.
One milestone: the first data on Choice in women. That is the point at which Choice becomes investable for a Series A or a strategic partner.
Design freeze of Choice ONE
The version that goes into the first studies in women.
First placements in women
Placement before a planned hysterectomy, with study of the removed tissue. Some women also go through removal.
Lab studies in parallel
Coatings and removal, in fallopian tube tissue grown in the lab.
Set-up of the pilot study
Multi-centre, in Europe and the US.
Regulatory preparation
EU MDR and FDA.
What is already there.
Built since 2014, with our own endoscope, a quality system and a network of specialists.
A short introduction first.
After a first conversation we share the investor deck and access to our data room, with the study plan, budget, patents and quality documentation. Every figure in it comes from one fact base.